Valuation: Edwards Lifesciences Corporation

Market Cap 5.23TCr 4.58TCr 4.22TCr 3.96TCr 7.42TCr 4,93100Cr 7.57TCr 51TCr 20TCr 2,43700Cr 20TCr 19TCr 8,45000Cr P/E 2026 *
32.4x
P/E 2027 * 27.7x
Enterprise Value 4.88TCr 4.28TCr 3.94TCr 3.69TCr 6.92TCr 4,60200Cr 7.07TCr 47TCr 18TCr 2,27500Cr 18TCr 18TCr 7,88700Cr EV / Sales 2026 *
7.23x
EV / Sales 2027 * 6.37x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day+1.18%
1 week+3.91%
Current month+4.98%
1 month+3.70%
3 months+10.57%
6 months+4.53%
Current year+6.49%
1 week 85.32
Extreme 85.315
92.46
1 month 83.17
Extreme 83.17
92.46
Current year 74.66
Extreme 74.66
92.46
1 year 72.3
Extreme 72.3
92.46
3 years 58.93
Extreme 58.93
96.12
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 11/05/2023
Director of Finance/CFO 43 29/05/2026
Chief Tech/Sci/R&D Officer 51 01/09/2025
Director TitleAgeSince
Chairman 69 07/05/2024
Director/Board Member 62 10/02/2015
Director/Board Member 58 11/05/2023
Date Insider Type Main position Quantity % Market Cap.
17/06Sell

Chief Executive Officer

-523 0.0001%
29/05Sell

Controller/Auditor

-568 0.0001%
27/05Sell

Executive/Senior Manager

-23,145 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
+1.18%+3.91%+17.67%+1.44% 5.23TCr
+1.44%+10.42%+24.49%-1.72% 19TCr
+1.25%-0.51%-24.24%+24.46% 14TCr
+1.75%+10.74%-2.62%-17.53% 14TCr
+0.07%-2.34%-57.71%-17.33% 6.57TCr
-0.52%-0.03%-26.94%-32.29% 4.35TCr
+0.37%+7.04%+13.89%+14.90% 3.84TCr
-0.66%+5.34%+5.49%+44.15% 3.68TCr
+1.26%+6.77%-12.16%-15.48% 2.99TCr
+0.85%+6.18%-21.83%-6.62% 2.89TCr
Average +0.70%+4.63%-8.39%-0.60% 7.68TCr
Weighted average by Cap. +1.03%+5.22%-4.52%-0.24%

Financials

2026 *2027 *
Net sales 674.8Cr 591.67Cr 545.38Cr 510.59Cr 957.44Cr 64TCr 977.31Cr 6.56TCr 2.54TCr 31TCr 2.53TCr 2.48TCr 1,09100Cr 741.05Cr 649.75Cr 598.92Cr 560.72Cr 1.05TCr 70TCr 1.07TCr 7.2TCr 2.79TCr 35TCr 2.78TCr 2.72TCr 1,19800Cr
Net income 162.43Cr 142.42Cr 131.28Cr 122.9Cr 230.46Cr 15TCr 235.25Cr 1.58TCr 610.54Cr 7.57TCr 609.92Cr 596.6Cr 26TCr 189.11Cr 165.81Cr 152.84Cr 143.09Cr 268.32Cr 18TCr 273.89Cr 1.84TCr 710.84Cr 8.82TCr 710.12Cr 694.61Cr 31TCr
Net Debt -348.23Cr -305.33Cr -281.44Cr -263.49Cr -494.08Cr -33TCr -504.34Cr -3.38TCr -1.31TCr -16TCr -1.31TCr -1.28TCr -56TCr -507.26Cr -444.77Cr -409.97Cr -383.82Cr -719.72Cr -48TCr -734.66Cr -4.93TCr -1.91TCr -24TCr -1.9TCr -1.86TCr -82TCr
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
26/26/26 $90.78 +1.18% 1,44,20,825
25/26/25 $89.72 +0.07% 43,18,766
24/26/24 $89.66 +3.12% 45,11,691
23/26/23 $86.95 +1.25% 42,28,237
22/26/22 $85.88 -1.69% 35,06,790
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
90.78USD
Average target price
96.92USD
Spread / Average Target
+6.77%

Quarterly revenue - Rate of surprise